EPISODE · Apr 29, 2026 · 2 MIN
Ionis Pharmaceuticals Soars with Blockbuster Drugs
from The Daily News Now! Business
Ionis Pharmaceuticals started the year strong with impressive sales from their drugs Trangolza and Donzara, which generated over $43 million in the first quarter. Both drugs are expanding internationally with partners Sobi and Otsuka. The demand for these medications is high, and doctors appreciate their profiles, including easy self-injection and significant triglyceride reduction. Ionis is preparing for two more solo launches this year, ozarsen and zilgarnirsen, with peak sales forecasts of over $3 billion and $2 billion, respectively. The companys financials are solid, with $1.9 billion in cash and improved operating losses. Ionis is also making progress in their pipeline, with partner wins like epiravirsen for hepatitis B and heart trials in the works. Overall, Ionis is becoming a commercial powerhouse, turning scientific advancements into patient and shareholder successes. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/581eef0beeb7d406
NOW PLAYING
Ionis Pharmaceuticals Soars with Blockbuster Drugs
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m